ReviewMedicine2026
Advancements in interventional gastroenterology GI tract cancers: A narrative review.
Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal (GI) tract cancers remain a leading cause of cancer-related morbidity and mortality worldwide, frequently presenting at advanced stages that limit curative treatment options. Traditional management has relied on surgery and systemic therapies; however, advances in interventional gastroenterology have significantly transformed diagnostic and therapeutic strategies. This narrative review aims to summarize recent advancements in interventional gastroenterology for GI cancers, focusing on evolving diagnostic tools, minimally invasive therapeutic techniques, and emerging technologies shaping modern oncologic care. A narrative review of current literature was conducted to evaluate developments in high-resolution imaging, image-enhanced endoscopy, endoscopic ultrasound, minimally invasive resection methods, ablative therapies, and palliative endoscopic interventions across esophageal, gastric, colorectal, pancreatic, and biliary malignancies. Advanced endoscopic techniques have improved early cancer detection, enabled precise staging, and facilitated organ-preserving treatment for early-stage malignancies. Interventional approaches also provide effective palliation in advanced disease. Emerging innovations, including artificial intelligence, robotic-assisted endoscopy, and endoscopic molecular diagnostics, are expanding the role of endoscopy in personalized cancer management. The integration of advanced interventional gastroenterology into multidisciplinary cancer care represents a paradigm shift toward personalized, minimally invasive management of GI malignancies, with significant potential to improve clinical outcomes and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.